Showing results (21-30 of 208) with videos related to
Sort By:
Pageof 21
Molecular Endocrinology (Baltimore, Md.)|April 5, 2008
Estrogen receptor-alpha hinge-region lysines 302 and 303 regulate receptor degradation by the proteasomeNicholas B Berry, Meiyun Fan, Kenneth P NephewJournal of Cancer Science and Clinical Therapeutics|December 18, 2023
Cholesterol Biosynthesis Inhibitor RO 48-8071 Suppresses Growth of Epithelial Ovarian Cancer Cells in Vitro and In VivoYayun Liang, Kenneth P Nephew, Salman M HyderAnti-Cancer Drugs|April 23, 2005
Dose-dependent effects of 4-hydroxytamoxifen, the active metabolite of tamoxifen, on estrogen receptor-alpha expression in the rat uterusChad A Reed, Amy K Berndtson, Kenneth P NephewMolecular Cancer Therapeutics|March 31, 2021
Targeting Ovarian Cancer Stem Cells by Dual Inhibition of HOTAIR and DNA MethylationWeini Wang, Fang Fang, Ali Ozes, et al.BMC Systems Biology|February 4, 2017
Subtype-specific CpG island shore methylation and mutation patterns in 30 breast cancer cell linesHeejoon Chae, Sangseon Lee, Kenneth P Nephew, et al.Bioinformatics (Oxford, England)|October 2, 2014
BioVLAB-MMIA-NGS: microRNA-mRNA integrated analysis using high-throughput sequencing dataHeejoon Chae, Sungmin Rhee, Kenneth P Nephew, et al.Cancer Research|April 6, 2021
How Epigenetic Therapy Beats Adverse Genetics in Monosomy Karyotype AMLHeather M O'Hagan, Feyruz V Rassool, Kenneth P NephewMolecular Cancer Therapeutics|July 23, 2008
Apigenin inhibits antiestrogen-resistant breast cancer cell growth through estrogen receptor-alpha-dependent and estrogen receptor-alpha-independent mechanismsXinghua Long, Meiyun Fan, Robert M Bigsby, et al.American Journal of Obstetrics and Gynecology|November 18, 2004
The epigenetics of ovarian cancer drug resistance and resensitizationCurtis Balch, Tim H-M Huang, Robert Brown, et al.Oncotarget|August 27, 2016
EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cellsHoracio Cardenas, Janice Zhao, Edyta Vieth, et al.Pageof 21